Protective effects of glutathione on bromodichloromethane in vivo toxicity and in vitro macromolecular binding in fischer 344 rats

Journal of Toxicology and Environmental Health

Volumn 49, Issue 2, 1996, Pages 145-159

  Gao, Pu ^a   Thornton Manning, Janice R ^b,d   Pegram, Rex A ^c  

^a ALION SCIENCE AND TECHNOLOGY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d Inhalation Toxicology Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMODICHLOROMETHANE; BUTHIONINE SULFOXIMINE; GLUTATHIONE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HISTOLOGY; IN VITRO STUDY; KIDNEY NECROSIS; LIVER MICROSOME; LIVER NECROSIS; LIVER TOXICITY; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

ANIMALS; BODY WEIGHT; BUTHIONINE SULFOXIMINE; ENZYME INHIBITORS; GLUTATHIONE; HYDROCARBONS, HALOGENATED; KIDNEY; LIPID METABOLISM; LIVER; MALE; MICROSOMES; ORGAN SIZE; PROTEIN BINDING; RATS; RATS, INBRED F344; SUBCELLULAR FRACTIONS; TRIHALOMETHANES;

ANIMALIA;

EID: 0029956530     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/00984108.1996.10662175     Document Type: Article

References (41)

1. Agency for Toxic Substances and Disease Registry. 1989. Toxicological Profile for Bromodichloro-methane. Report no. ATSDR/TP89/04. Atlanta, CA: U.S. Public Health Service, ATSDR.
2. Anders, M. W., Stevens, J. L., Sprague, R. W., Shaath, Z., and Ahmed, A. E. 1978. Metabolism of haloforms to carbon monoxide. II. In vivo studies. Drug Metab. Dispos. 6:556-560.
3. Anderson, M. E. 1985. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113:548-551.
4. 14C]chloroform by different species. Xenobiotica 4:151-163.
5. Cantor, K. P., Hoover, R., Mason, T. J., and McCabe, J. L. 1978. Associations of cancer mortality with halomethanes in drinking water. J. Natl. Cancer Inst. 4:979-985.
6. Connor, H. D., Lacagnin, L. B., Knecht, K. T., Thurman, R. G., and Mason, R. P. 1989. Reaction of glutathione with a free radical metabolite of carbon tetrachloride. Mol. Pharmacol. 37:443-451.
7. Cresteil, T., Beaune, P., Leroux, J. P., Lange, M., and Mansuy, D. 1979. Biotransformation of chloroform by rat and human liver microsomes; in vitro effect on some enzyme activities and mechanism of irreversible binding to macromolecules. Chem. Biol. Interact. 24:153-165.
8. De Biasi, A., Sbraccia, M., Keizer, J., Testai, E., and Vittozzi, L. 1992. The regioselective binding of chloroform reactive intermediates to microsomal phospholipids. Chem. Biol. Interact. 85:229-242.
9. Docks, E. L., and Krishna, G. 1976. The role of glutathione in chloroform-induced hepatotoxicity. Exp. Mol. Pathol. 24:13-22.
10. Englander, S. W., Calhoun, D. B., and Englander, J. J. 1987. Biochemistry without oxygen. Anal. Biochem. 161:300-306.
11. Gao, P., and Pegram, R. A. 1992. In vitro hepatic microsomal lipid and protein binding by metabolically activated bromodichloromethane. Toxicologist 12:421.
12. Griffith, O. W., and Meister, A. 1979. Glutathione: Interorgan translocation, turnover, and metabolism. Proc. Natl. Acad. Sci. USA 76:5606-5610.
13. Ilett, K. F., Reid, W. D., Sipes, I. G., and Krishna, G. 1973. Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules. Exp. Mol. Pathol. 19:215-229.
14. Ketterer, B. 1988. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat. Res. 202:343-361.
15. Kluwe, W. M., and Hook, J. B. 1981. Potentiation of acute chloroform nephrotoxicity by the glutathione depletor diethyl maleate and protection by the microsome enzyme inhibitor piperonyl butoxide. Toxicol. Appl. Pharmacol. 59:457-466.
16. Kroll, R. B., Robinson, G. D., and Chung, J. H. 1994a. Characterization of trihalomethane (THM)-induced renal dysfunction in the rat. I: Effects of THM on glomerular filtration and renal concentrating ability. Arch. Environ. Contam. Toxicol. 27:1-4.
17. Kroll, R. B., Robinson, G. D., and Chung, J. H. 1994b. Characterization of trihalomethane (THM)-induced renal dysfunction in the rat. II: Relative potency of THMs in promoting renal dysfunction. Arch. Environ. Contam. Toxicol. 27:5-7.
18. Lilly, P. D., Moore, T. C., and Pegram, R. A. 1994a. Comparative renal and hepatic toxicity of bromodichloromethane (BDCM) and chloroform (CHCI,) following acute oral aqueous administration to rats. Toxicologist 14:280.
19. Lilly, P. D., Simmons, J. E., and Pegram, R. A. 1994b. Dose-dependent vehicle differences in the acute toxicity of bromodichloromethane. Fundam. Appl. Toxicol. 23:132-140.
20. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent.J. Biol. Chem. 193:265-275.
21. Mansuy, D., Beaune, T., Crested, T., Lange, M., and Leroux, J. P. 1977. Evidence for phosgene formation during liver microsomal oxidation of chloroform. Biochem. Biophys. Res. Commun. 79:513-517.
22. Mathews, J. M., Troxler, P. S., and Jeffcoat, A. R. 1990. Metabolism and distribution of bromodichloromethane in rats after single and multiple oral doses. J. Toxicol. Environ. Health 30:15-22.
23. Morris, R. D., Audet, A., AngeliIlo, I. F., Chalmers, T. C., and Mosteller, F. 1992. Chlorination, chlorination by-products, and cancer: a meta-analysis. Am. J. Public Health 7:955-963.
24. National Toxicology Program. 1987. Toxicology and Carcinogenesis Studies of Bromodichloromethane in F344/N Rats and B6C3F1Mice. NIH publication 88-2537, NTP TR321. Research Triangle Park, NC: U.S. Department of Health and Human Services, National institutes of Health.
25. Pohl, L. R., Bhooshan, B., Whittaker, N. F., and Krishna, G. 1977. Phosgene: A metabolite of chloroform. Biochem. Biophys. Res. Commun. 79:684-691.
26. Pohl, L. R., Branchflower, R. V., Highet, R. J., Martin, J. L., Nunn, D. S., Monks, T. J., George, J. W., and Hinson, J. A. 1981. The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane, and carbon tetrachloride. Drug Metab. Dispos. 9:334-339.
27. Simmons, J. E., DeMarini, D. M., and Berman, E. 1988. Lethality and hepatotoxicity of complex waste mixtures. Environ. Res. 46:74-85.
28. Sipes, I. G., Krishna, G., and Gillette, J. R. 1977. Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: role of cytochrome P-450. Life Sci. 20:1541-1548.
29. Smith, J. H., and Hook, J. B. 1984. Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice. Toxicol. Appl. Pharmacol. 73:511-524.
30. Stevens, J. L., and Anders, M. W. 1979. Metabolism of haloforms to carbon monoxide. III. Studies on the mechanism of the reaction. Biochem. Pharmacol. 28:3189-3194.
31. Stevens, J. L., and Anders, M. W. 1981. Metabolism of haloforms to carbon monoxide. IV. Studies on the reaction mechanism in vivo. Chem. Biol. Interact. 37:365-374.
32. Testai, E., and Vittozzi, L. 1986. Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem. Biol. Interact. 59:157-171.
33. Testai, E., Di Marzio, S., and Vittozzi, L. 1990. Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1mice. Toxicol. Appl. Pharmacol. 104:496-503.
34. Testai, E., Gemma, S., and Vittozzi, L. 1992. Bioactivation of chloroform in hepatic microsomes from rodent strains susceptible or resistant to CHCI, carcinogenicity. Toxicol. Appl. Pharmacol. 114:197-203.
35. Thornton-Manning, J. R., Gao, P., Lilly, P. D., and Pegram, R. A. 1993. Acute bromodichloro-methane toxicity in rats pretreated with cytochrome P450 inducers and inhibitors. Toxicologist 13:361.
36. Thornton-Manning, J. R., Seely, J. C., and Pegram, R. A. 1994. Toxicity of bromodichloromethane in female rats and mice after repeated oral dosing. Toxicology 94:3-18.
37. Tomasi, A., Albano, E., Biasi, F., Slater, T. F., Vannini, V., and Dianzani, M. U. 1985. Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique. Chem. Biol. Interact. 55:303-316.
38. Uehleke, H. 1973. The model system of microsomal drug activation and covalent binding to endoplasmic proteins. Proc. Bur. Soc. Study Drug Tox. 15:119-129.
39. Uehleke, H., and Werner, T. 1975. A comparative study on the irreversible binding of labeled halothane, trichlorofluoromethanol, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo. Arch. Toxicol. 34:289-308.
40. Waller, C. L., and McKinney, J. D. 1993. Theoretical investigation into the potential of halo-genated methanes to undergo reductive metabolism.J. Comput. Chem. 14:1575-1579.
41. White, R. D., Norton, R., and Bus, J. S. 1984. The effect of buthionine sulfoximine, an inhibitor of glutathione synthesis, on hepatic drug metabolism in the male mouse. Toxicol. Lett. 23:25-32.